Email Newsletters

Life Sciences

Pharma A Force To Be Reckoned With In Bay State

Since the historic sequencing of the human genome a decade ago, pharmaceutical research and biotechnology companies in...

GTC Losses Continue

GTC Biotherapeutics, the Framingham-based drug manufacturer, moved closer to profitability in the second quarter, but still registered...

Westborough Man Indicted For Espionage

A Westborough man has been arrested on more than a dozen counts of economic espionage and transporting...

GTC Reclaims Commercialization Rights

GTC Biotherapeutics, the Framingham-based transgenic drug manufacturer, has reached an agreement to regain the rights...
ADVERTISEMENT

RXi Gets NIH Grant

Worcester's RXi Pharmaceuticals has won a $600,000 grant from the National Institutes of Health for pre-clinical development...

Management Change To Breathe New Life Into GTC

  William Heiden, the newly anointed president and CEO of the Framingham biotech firm GTC Biotherapeutics, admits...

Boxborough Co. Partners For Service Support

Groton Biosystems of Boxborough has entered a partnership with Mansfield-based New England Controls to provide data systems...

Genzyme To Buy Back $1B In Stock

Cambridge-based biotech and pharmaceuticals giant Genzyme Corp. has ramped up a $1 billion accelerated stock repurchase program.Through...
ADVERTISEMENT

GTC Bio Axes CEO, 50 Staffers

Framingham-based GTC Biotherapeutics Inc. has secured $7 million in debt financing from its French partner LFB Biotechnologies,...

Science & Business | How Caliper Life Sciences has exploited industry trends on its quest for profitability

The life sciences industry still faces big hurdles, from hard-to-come-by financing to the ever rising cost of...
ADVERTISEMENT

Latest Stories

More Business News
ADVERTISEMENT

Thought Leadership

More Thought Leadership

Career Opportunities

More Jobs | Submit a Job
More Events | Submit an Event

Get our email newsletter

Stay up-to-date on the companies, people and issues that impact businesses in Central Massachusetts.

Close the CTA